Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal

Clinical and Experimental Nephrology

Volumn 9, Issue 1, 2005, Pages 62-68

  Kazama, Itsuro ^a   Matsubura, Mitsunobu ^a   Ejima, Yutaka ^b   Michimata, Mari ^a   Suzuki, Michiko ^a   Miyama, Noriyuki ^b   Sato, Akira ^b   Sato, Hiroshi ^c   Ito, Sadayoshi ^c  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Childhood onset; Prolonged type I MPGN; Steroid resistance; Type I membranoproliferative glomerulonephritis (type I MPGN); Withdrawal from steroid

Indexed keywords

DIPYRIDAMOLE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; GLOMERULONEPHRITIS; HOSPITAL DISCHARGE; HUMAN; KIDNEY BIOPSY; MESANGIUM CELL; PROTEINURIA; REMISSION; TYPE I MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLUCOCORTICOIDS; HUMANS; KIDNEY; PREDNISOLONE; REMISSION INDUCTION; TIME FACTORS;

EID: 17744381230     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0329-4     Document Type: Article

References (27)

1. Johnson RJ, Alpers CE, Schena FP. Membranoproliferative glomerulonephritis and cryoglobulinemic glomerulonephritis. In: Johnson RJ, Feehally J, editors. comprehensive clinical nephrology. London: Mosby, 2000; 5.25.1-10.
2. Ford DM, Briscoe DM, Shanley PF, Lum GM. Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy. Kidney Int 1992;41:1606-12.
3. McEnery PT, McAdams AJ, West CD. The effect of prednisone in a high-dose, alternative-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine (Baltim) 1986;64:401-24.
4. Harmankaya O, Basturk T, Ozturk Y, Karabiber N, Obek A. Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type. Int Urol Nephrol 2001;33:583-7.
5. Warady BA, Guggenheim SJ, Sedman A, Lum GM. Prednisone therapy of membranoproliferative glomerulonephritis in children. J Pediatr 1985;107:702-7.
6. McEnery PT. Membranoproliferative glomerulonephritis. The Cincinnati experience - cumulative renal survival from 1957 to 1989. J Pediatr 1990;116:S109-14.
7. Tarshish P, Berstein J, Tobin J, Edelmann C. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone: a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 1992;6:123-30.
8. Bergstein JM, Andreoli SP. Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy. Pediatr Nephrol 1995;9:268-71.
9. Schena FP, Cameron JS. Treatment of proteinuric idiopathic glomerulonephritis: a retrospective survey. Am J Med 1988;85:315-26.
10. Levin A. Management of membranoproliferative glomerulonephritis. Evidence-based recommendations. Kidney Int 1999;55:S41-6.
11. D'Amico G, Ferrario F. Mesangiocapillary glomerulonephritis. J Am Soc Nephrol 1992;2:S159-66.
12. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term progression of membranoproliferative glomerulonephritis type I. Nephron 1990;55:242-50.
13. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature. Am J Kidney Dis 1992;20:315-23.
14. Nakamura T, Obata JE, Onitsuka M, Shimada Y, Yoshida Y, Kawachi H, et al. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis. Nephron 2000;86:315-26.
15. Yoshimura A, Nemoto T, Sugenoya Y, Inui K, Watanabe S, Inoue Y, et al. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression. Kidney Int Suppl 1999;71:S84-7.
16. Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis. Am J Med 1983;75:920-7.
17. Donadio JV Jr, Anderson CF, Mitchell JC III, Holley KE, Ilstrup DM, Fuster V, et al. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med 1984;310:1421-6.
18. Butani L. Remission of membranoproliferative nephritis with angiotensin converting enzyme inhibition and receptor blockade. Pediatr Nephrol 2003;18:1199.
19. Loustaud-Ratti V, Liozon E, Karaaslan H, Alain S, Paraf F, Meur YL, et al. Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection. Am J Med 2002;113:516-9.
20. Dussol B, Moal V, Daniel L, Pain C, Berland Y. Spontaneous remission of HCV-induced cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 2001;16:156-9.
21. Perez-Calvo J, Lasierra P, Moros M, Inigo P. Role of ribavirin in membranoproliferative glomerulonephritis associated with hepatitis C virus infection refractory to alpha-interferon. Nephron 2002;92:459-62.
22. Sabry AA, Sobh MA, Sheaashaa HA, Kudesia G, Wild G, Fox S, et al. Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy. Nephrol Dial Transplant 2002;17:1924-30.
23. Chidamabaram M, Stigant CE, Sugar LM, Ramesh Prasad GV. Type I membranoproliferative glomerulonephritis in an HIV-infected individual without hepatitis C co-infection. Clin Nephrol 2002;57:154-7.
24. Andresdottir MB, Assmann KJM, Hilbrands LB, Wetzels JFM. Primary Epstein-Barr virus infection and recurrent type I membranoproliferative glomerulonephritis after renal transplantation. Nephrol Dial Transplant 2000;15:1235-7.
25. Ligny BH, Francois IEA, Toupance O, Buchler M, Touchard G, et al. Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc 2000;32:2760-1.
26. Berthoux P, Laurent B, Cecillon S, Berthoux F. Membranoproliferative glomerulonephritis with subendothelial deposits (type 1) associated with hepatitis G virus infection in a renal transplant recipient. Am J Nephrol 1999;19:513-8.
27. di Belgiojoso GB, Ferrario F, Landriani N. Virus-related glomerular diseases: histological and clinical aspects. J Nephrol 2002;15:469-79.